Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin E Versus Silymarin in Non-Diabetic MASLD Patients
NCT07863648Phase 3Not yet recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Oct 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin e, silymarin in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Kafrelsheikh University. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
vitamin esilymarin
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on NCT07863648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07863648.